751 related articles for article (PubMed ID: 25894147)
41. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
[TBL] [Abstract][Full Text] [Related]
42. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
[TBL] [Abstract][Full Text] [Related]
43. Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence.
Korda D; Lenard ZM; Gerlei Z; Jakab Z; Haboub-Sandil A; Wagner L; Varga M; Cseprekal O; Marton A; Horvathy D; Takacs S; Doros A; Mathe Z
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):27-32. PubMed ID: 29049126
[TBL] [Abstract][Full Text] [Related]
44. Incidence of Post-Liver Transplant Hepatic Dysfunction After Sustained Virologic Response Following Direct-Acting Anti-Hepatitis C Therapy.
Jain A; Riley TR; Krok KL; Schreibman I; Karamchandani DM; Liao X; Tian Y; Dohi T; Kadry Z
Exp Clin Transplant; 2020 Jun; 18(3):345-352. PubMed ID: 30295586
[TBL] [Abstract][Full Text] [Related]
45. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients.
Saab S; Greenberg A; Li E; Bau SN; Durazo F; El-Kabany M; Han S; Busuttil RW
Liver Int; 2015 Nov; 35(11):2442-7. PubMed ID: 25913321
[TBL] [Abstract][Full Text] [Related]
46. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection.
Molmenti EP; Jain AB; Shapiro R; Scantlebury V; Lee R; Totsuka E; Flohr J; Rakela J; Fung JJ
Transplantation; 2001 Jan; 71(2):267-71. PubMed ID: 11213072
[TBL] [Abstract][Full Text] [Related]
47. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
[TBL] [Abstract][Full Text] [Related]
48. Impact of Sustained Viral Response With Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients.
Saab S; Barnard A; Challita Y; Adeniyi A; Aziz A; Choi G; Durazo FA; El-Kabany MM; Han SB; Busuttil RW
Exp Clin Transplant; 2018 Aug; 16(4):419-424. PubMed ID: 30060729
[TBL] [Abstract][Full Text] [Related]
49. Treatment of hepatitis C virus infection in kidney transplant recipients: case report.
Caeiro F; Baptista V; Rodrigues N; Carvalho D; Aires I; Remédio F; Nolasco F
Transplant Proc; 2011; 43(1):259-62. PubMed ID: 21335201
[TBL] [Abstract][Full Text] [Related]
50. Treatment of Chronic Hepatitis C Infection Among Egyptian Kidney Transplant Recipients: A Pilot Study.
El Maghrabi HM; Elmowafy AY; Donia AF; Ismail MI; El-Hendy YA; Soliman R; Shiha GE; Bakr MA
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):62-67. PubMed ID: 30777525
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis C virus genotypes and the influence of the induction of immunosuppression with anti-thymocyte globulin (ATG) on chronic hepatitis in renal graft recipients.
Rodrigues A; Pinho L; Lobato L; Queirós A; Castro R; Daniel M; Dias L; Henriques AC; Sarmento A; Guimarães S
Transpl Int; 1998; 11 Suppl 1():S115-8. PubMed ID: 9664959
[TBL] [Abstract][Full Text] [Related]
52. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.
Rostaing L; Izopet J; Cisterne JM; Arnaud C; Duffaut M; Rumeau JL; Puel J; Durand D
Transplantation; 1998 Apr; 65(7):930-6. PubMed ID: 9565097
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of Hepatitis C-Positive Kidney Transplant Recipients Compared With Hepatitis C-Negative Recipients in Today's Era of Immunosuppression: A UNOS Database Analysis With Long-Term Follow-Up.
Khalil A; Mujtaba MA; Aljanabi OT; Ghabril MS; Taber TE; Yaqub MS; Sharfuddin A
Exp Clin Transplant; 2017 Jun; 15(3):282-288. PubMed ID: 27310008
[TBL] [Abstract][Full Text] [Related]
54. Posttransplant De Novo Hepatitis C Virus Infection in Renal Transplant Recipients: Its Impact on Morbidity and Mortality.
Hanif FM; Laeeq SM; Luck NH; Aziz T; Abbas Z; Mubarak M
Exp Clin Transplant; 2017 Feb; 15(1):56-60. PubMed ID: 27915964
[TBL] [Abstract][Full Text] [Related]
55. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
[TBL] [Abstract][Full Text] [Related]
56. Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.
Reese PP; Abt PL; Blumberg EA; Van Deerlin VM; Bloom RD; Potluri VS; Levine M; Porrett P; Sawinski D; Nazarian SM; Naji A; Hasz R; Suplee L; Trofe-Clark J; Sicilia A; McCauley M; Gentile C; Smith J; Niknam BA; Bleicher M; Reddy KR; Goldberg DS
Ann Intern Med; 2018 Sep; 169(5):273-281. PubMed ID: 30083748
[TBL] [Abstract][Full Text] [Related]
57. Detection of Hepatis C Virus-Related Immunologic Markers and Their Impact on Outcomes of Living-Donor Kidney Transplant Recipients.
Denewar AA; Abbas MH; Sheashaa HA; Abdelaal I; El-Dahshan K; Matter YE; Refaie AF
Exp Clin Transplant; 2019 Feb; 17(1):79-83. PubMed ID: 29957163
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis B- and hepatitis D-virus-related liver transplant: single-center data.
Öcal S; Korkmaz M; Harmancı Ö; Ensaroğlu F; Akdur A; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():133-8. PubMed ID: 25894142
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis C Virus in the Renal Transplant Population: An Update With Focus on the New Era of Antiviral Regimens.
Gheith O; Halim MA; Othman N; Al-Otaibi T; Nair P; Nampoory N
Exp Clin Transplant; 2017 Feb; 15(1):10-20. PubMed ID: 27915966
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis C--associated glomerular disease in liver transplant recipients.
Davis CL; Gretch DR; Perkins JD; Harris AW; Wener MH; Alpers CE; Lesniewski R; Lee W; dela Rosa C; Johnson RJ
Liver Transpl Surg; 1995 May; 1(3):166-75. PubMed ID: 9346560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]